EP3 Receptor Deficiency Improves Vascular Remodeling and Cognitive Impairment in Cerebral Small Vessel DiseaseAGING AND DISEASEIF6.92022-01-015OAAI
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled studyBRITISH JOURNAL OF CANCERIF6.82019-08-0613OAAI
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trialBRITISH JOURNAL OF CANCERIF6.82018-06-149OAAI